Women’s Health Brochure: Ovarian Cancer

-819150-828675Preventive ScreeningThis entails transvaginal ultrasound and CA125. The contemporary clinically feasible approaches for ovarian cancer screening are mainly limited to physician evaluation by clinicians, assessment of serum level of cancer antigen protein biomarker (CA125), and adnexa imaging using transvaginal ultrasound (TVU). In this context, TVU is the primarily used imaging technique to detect ovarian cancer, as well as allows clinicians to establish irregularities in the ovarian tissue shape and size. CA125 is mainly used as an ovarian cancer biomarker to develop cancer cell metastasis and growth (Liberto et al., 2022).Disease Overview and ProcessOvarian cancer is an illness whereby the growth of abnormal cells in the body is beyond control. It usually starts in the ovary, fallopian tubes, or peritoneum and spreads to other body parts in subsequent stages (Centers for Disease Control and Prevention, 2023). Ovarian cancer is attributed to a significant share of maternal deaths in the United States (U.S.). The escalating poor outcomes due to the disease emanates from the premise that the illness is typically diagnosed in advanced stages, which makes it challenging to make corrective treatments and related interventions. Treatment works best when the illness is established in its early phases (Arora et al., 2023).Ovarian CancerFemale Reproductive Disorder 0Preventive ScreeningThis entails transvaginal ultrasound and CA125. The contemporary clinically feasible approaches for ovarian cancer screening are mainly limited to physician evaluation by clinicians, assessment of serum level of cancer antigen protein biomarker (CA125), and adnexa imaging using transvaginal ultrasound (TVU). In this context, TVU is the primarily used imaging technique to detect ovarian cancer, as well as allows clinicians to establish irregularities in the ovarian tissue shape and size. CA125 is mainly used as an ovarian cancer biomarker to develop cancer cell metastasis and growth (Liberto et al., 2022).Disease Overview and ProcessOvarian cancer is an illness whereby the growth of abnormal cells in the body is beyond control. It usually starts in the ovary, fallopian tubes, or peritoneum and spreads to other body parts in subsequent stages (Centers for Disease Control and Prevention, 2023). Ovarian cancer is attributed to a significant share of maternal deaths in the United States (U.S.). The escalating poor outcomes due to the disease emanates from the premise that the illness is typically diagnosed in advanced stages, which makes it challenging to make corrective treatments and related interventions. Treatment works best when the illness is established in its early phases (Arora et al., 2023).Ovarian CancerFemale Reproductive Disorder
-800100-914400Signs and SymptomsAbdominal swelling and bloatingSignificant loss of weightQuickly feeling full when eatingBack painFatigueDiscomfort within the pelvic regionFrequent urinationConstipation or changes in bowel movements (Mayo Clinic, n.d).TreatmentThere are various treatment modalities that the physician may recommend including:Debulking surgeryPrimary debulking surgery and neoadjuvant chemotherapyMaximal cytoreductive surgeryNeoadjuvant therapy and primary chemotherapyChemotherapy among elderly patients, andMaintenance therapy (Arora et al., 2023).Risk FactorsThere are many risk factors for ovarian cancer. Postmenopausal women are at a high risk of being diagnosed with the illness. Age is associated with increased prevalence of the disease, advanced illness stage, and high associated mortality rates. The primary risk factor is a family history of ovarian or breast cancer, which increases the vulnerability to developing cancerous cells. Lastly, smoking increases the risk of mucinous ovarian cancer (Arora et al., 2...